恶性梗阻性黄疸的介入治疗进展
Advances in the Interventional Treatment of Malignant Obstructive Jaundice
DOI: 10.12677/ACM.2023.1361408, PDF,   
作者: 王彦昭：青海大学研究生院，青海 西宁；陈鲜霞*：青海省人民医院超声科，青海 西宁
关键词: 恶性梗阻性黄疸；介入治疗；ERCP；PTCD；Malignant Obstructive Jaundice； Interventional Therapy； ERCP； PTCD
摘要: 近年来胆系恶性肿瘤的发病率呈现出持续上升的趋势，对人们的身体健康和生命安全构成了极为严重的威胁。恶性梗阻性黄疸(MOJ)是由于各类恶性因素而导致的疾病，通常而言这种疾病是因为恶性肿瘤导致胆管系统直接性或间接性狭窄，并在这种情况下造成患者的胆汁淤积问题，在这一疾病之下患者将有较大可能性出现高胆红素血症、凝血功能障碍及肝功能障碍等并发症，对患者的影响极为巨大，因此现阶段针对该疾病的治疗成为人们广泛关注的问题。本文对现阶段恶性梗阻性黄疸的介入治疗进展进行了综述，期望对后续的治疗和研究形成一定的启示。
Abstract: In recent years, the incidence of biliary malignant tumors has been increasing, which poses a seri-ous threat to peoples’ health and life safety. Malignant obstructive jaundice (MOJ) is a disease caused by a variety of malignant factors, usually due to direct or indirect strictures of the bile duct system caused by malignant tumors; in this case, the patient will have cholestasis, under which the patient will be more likely to develop complications such as hyperbilirubinemia, coagulopathy and liver dysfunction; the impact on patients is so great that the treatment of this disease has become a widespread concern at this stage. This article reviews the progress of interventional therapy for malignant obstructive jaundice at present, and expects to give some enlightenment to the follow-up treatment and research.
文章引用：王彦昭, 陈鲜霞. 恶性梗阻性黄疸的介入治疗进展[J]. 临床医学进展, 2023, 13(6): 10069-10074. https://doi.org/10.12677/ACM.2023.1361408

参考文献

[1] Xing, D., Song, W., Gong, S., et al. (2022) Analysis of the Bacterial Spectrum and Key Clinical Factors of Biliary Tract Infection in Patients with Malignant Obstructive Jaundice after PTCD. Disease Markers, 2022, Article ID: 1026254. [Google Scholar] [CrossRef] [PubMed]
[2] Sportes, A., Camus, M., Greget, M., et al. (2017) Endoscopic Ultra-sound-Guided Hepaticogastrostomy versus Percutaneous Transhepatic Drainage for Malignant Biliary Obstruction after Failed Endoscopic Retrograde Cholangiopancreatography: A Retrospective Expertise-Based Study from Two Centers. Therapeutic Advances in Gastroenterology, 10, 483-493. [Google Scholar] [CrossRef] 
[3] 徐辉. 改良经皮肝穿刺胆道支架置入术治疗老年恶性梗阻性黄疸患者的临床效果[J]. 医疗装备, 2019, 32(22): 137-138.
[4] Luo, J., Shao, G.L., Yao, H.X., et al. (2022) The Efficacy and Safety of Biliary Stenting Alone versus Stenting Combined with Iodine-125 Seed Strand Implantation for the Treatment of Cholangiocarcinoma with Malignant Obstructive Jaundice: A Prospective, Nonrandomized, Controlled Clinical Study. Annals of Palliative Medicine, 11, 2422-2431. [Google Scholar] [CrossRef] [PubMed]
[5] 乔秀丽, 宋文冲, 李爱君, 等. 晚期恶性梗阻性黄疸支架置入术后感染的细菌学分析[J]. 实用医学杂志, 2013, 29(10): 1603-1605.
[6] 许哲, 徐明林, 赵健宇. PTCD及金属支架植入配合超选择动脉灌注化疗治疗恶性梗阻性黄疸的临床效果观察[J]. 中国实用医药, 2022, 17(16): 23-26.
[7] 郑小静, 郝晓玲, 陈秀梅, 等. 探讨三种挤压方法对PTCD管引流效果的随机对照研究[J]. 中华介入放射学电子杂志, 2021, 9(4): 452-455.
[8] Khashab, M.A., Valeshabad, A.K., Modayil, R., et al. (2013) EUS-Guided Biliary Drainage by Using a Standardized Approach for Malignant Biliary Obstruction: Rendezvous versus Direct Transluminal Techniques (with Videos). Gastrointestinal Endoscopy, 78, 734-741. [Google Scholar] [CrossRef] [PubMed]
[9] 曹虎, 刘萍平, 刘金芳. 内镜下逆行胰胆管造影术治疗胰腺癌导致的梗阻性黄疸的临床疗效[J]. 中外医疗, 2020, 39(19): 41-43.
[10] Gomez, T.K.M., Molina, V.C., Miras, L.L., et al. (2022) Choledochoduodenostomy with LAMS (Hot-Axios Type) for Malignant Obstructive Jaundice—An Increasingly Used Technique. Revista Espanola De Enfer-medades Digestivas, 114, 558-559. [Google Scholar] [CrossRef] [PubMed]
[11] 李敏利, 吕莉慧, 金鑫鑫, 等. 内镜下逆行胰胆管造影术在老年患者不同类型梗阻性黄疸中的应用价值[J]. 胃肠病学和肝病学杂志, 2017, 26(3): 335-337.
[12] 周洪波. 两种不同途径胆道金属支架植入治疗恶性阻塞性黄疸的对比研究[J]. 中国实用医药, 2019, 14(27): 34-36.
[13] 王勇. 经内镜逆行性胰胆管造影与经皮肝穿刺胆道引流金属支架置入治疗恶性阻塞性黄疸的疗效比较[J]. 系统医学, 2018, 3(11): 78-79+82.
[14] Wang, H.B., Peng, F., Wang, M., et al. (2021) Im-pact of Percutaneous Transhepatic Biliary Drainage on Clinical Outcomes of Patients with Malignant Obstructive Jaun-dice Undergoing Laparoscopic Pancreaticoduodenectomy. Current Medical Science, 41, 375-380. [Google Scholar] [CrossRef] [PubMed]
[15] Sarkodie, B.D., Botwe, B.O. and Brakohiapa, E.K.K. (2020) Per-cutaneous Transhepatic Biliary Stent Placement in the Palliative Management of Malignant Obstructive Jaundice: Initial Experience in a Tertiary Center in Ghana. The Pan African Medical Journal, 37, Article No. 96. [Google Scholar] [CrossRef] [PubMed]
[16] Rizzo, A., Ricci, A.D., Frega, G., et al. (2020) How to Choose between Percutaneous Transhepatic and Endoscopic Biliary Drainage in Malignant Obstructive Jaundice: An Updated Systematic Review and Meta-Analysis. In Vivo, 34, 1701-1714. [Google Scholar] [CrossRef] [PubMed]
[17] Gerger, H., Werner, C.P., Gaab, J., et al. (2021) Comparative Efficacy and Acceptability of Expressive Writing Treatments Compared with Psychotherapy, Other Writing Treatments, and Waiting List Control for Adult Trauma Survivors: A Systematic Review and Network Meta-Analysis. Psychological Medicine, 52, 3484-3496. [Google Scholar] [CrossRef] 
[18] Chen, W.Y., Kong, C.L., Meng, M.M., et al. (2021) Percutane-ous Biliary Stent Combined with Brachytherapy Using (125)I Seeds for Treatment of Unresectable Malignant Obstruc-tive Jaundice: A Meta-Analysis. World Journal of Clinical Cases, 9, 10979-10993. [Google Scholar] [CrossRef] [PubMed]
[19] 周宇航, 黄永辉. 肝外胆管狭窄的内镜治疗进展[J]. 中国微创外科杂志, 2021, 21(9): 831-837.
[20] Uyanik, S.A., Oguslu, U., Cevik, H., et al. (2021) Percutaneous Endobiliary Ablation of Malignant Biliary Strictures with a Novel Temperature-Controlled Radiofrequency Ablation Device. Diag-nostic and Interventional Radiology, 27, 102-108. [Google Scholar] [CrossRef] [PubMed]
[21] 牛旭, 冯章东, 张腾, 等. 经皮肝穿刺胆道引流术和内镜下胆管内引流术对晚期恶性梗阻性黄疸患者围术期指标和术后并发症的影响[J]. 川北医学院学报, 2022, 37(3): 378-381+410.
[22] Park, D.H., Lee, S.S., Park, S.E., et al. (2014) Random-ised Phase II Trial of Photodynamic Therapy plus Oral Fluoropyrimidine, S-1, versus Photodynamic Therapy Alone for Unresectable Hilar Cholangiocarcinoma. European Journal of Cancer, 50, 1259-1268. [Google Scholar] [CrossRef] [PubMed]
[23] 唐宗怀, 陈勇, 李子杰, 等. 经皮肝穿刺胆道支架植入治疗老年恶性梗阻性黄疸的临床效果观察[J]. 北京医学, 2021, 43(2): 165-167.
[24] Shabunin, A.V., Tavobilov, M.M., Lebedev, S.S., et al. (2020) Mechanisms and Prevention of Biliary Stent Occlusion. Khirurgiia (Mosk), No. 5, 70-75. [Google Scholar] [CrossRef] [PubMed]
[25] Shestopalov, S.S., Mikhailova, S.A., Abramov, E.I., et al. (2019) Management of Patients with Malignant Obstructive Jaundice Using Bile Examination after External Biliary Drainage. Khirurgiia (Mosk), No. 2, 40-46. [Google Scholar] [CrossRef] [PubMed]
[26] Wu, J.Z., Li, C.L., Shi, H.B., et al. (2022) Hepatic Arterial Infu-sion Chemotherapy Following Simultaneous Metallic Stent Placement and Iodine-125 Seed Strands for Advanced Chol-angiocarcinoma Causing Malignant Obstructive Jaundice: A Propensity Score Matching Study. Japanese Journal of Ra-diology, 40, 396-403. [Google Scholar] [CrossRef] [PubMed]
[27] Qi, S. and Yan, H. (2021) Effect of Percutaneous Transhepatic Cholangial Drainag + Radiofrequency Ablation Combined with Biliary Stent Implantation on the Liver Function of Pa-tients with Cholangiocarcinoma Complicated with Malignant Obstructive Jaundice. American Journal of Translational Research, 13, 1817-1824.
[28] Liu, C., Xing, W., Si, T., et al. (2020) Should the Oddis Sphincter Be Retained? A Clin-ical Analysis of Biliary Metal Stent Implantation in Patients with Malignant Obstructive Jaundice. Journal of Cancer Re-search and Therapeutics, 16, 1119-1124. [Google Scholar] [CrossRef] 

为你推荐